• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Severe COVID-19 Induces An Immune Response That May Be Able To Fight Cancer

November 28, 2024 by Deborah Bloomfield

A surprising finding in a mouse model could lead us to a new way of treating some types of cancer, with a helping hand from an unlikely source: COVID-19. An immune mechanism that was activated in the mice when they were given drugs to simulate severe COVID-19 had the side effect of fighting cancer, causing four types of tumors to shrink.

Finding ways to turn the body’s own immune system against cancerous cells has represented something of a revolution in oncology in recent decades. While the ideas underpinning immunotherapies go back much further than many appreciate, as the Cancer Research Institute points out, “As of 2019, immunotherapy has permanently changed the cancer treatment landscape.” 

Advertisement

A major milestone was the awarding of the 2018 Nobel Prize in Physiology or Medicine to James P. Allison and Tasuku Honjo for their work in this field. 

While many immunotherapies have shown great success and benefited countless patients, there remain those whose cancers are resistant to the current treatments. Researchers are always working towards new and improved approaches, and this recent serendipitous finding in mice could lead to a promising new avenue.

“The study here focused on a type of white blood cell called monocytes,” explained Justin Stebbing – a professor of biomedical sciences at Anglia Ruskin University who was not directly involved in the new study – in an article for The Conversation.

“These immune cells play a crucial role in the body’s defence against infections and other threats. However, in cancer patients, monocytes can sometimes be hijacked by tumour cells and transformed into cancer-friendly cells that protect the tumour from the immune system.”

Advertisement

But under certain conditions, the study authors discovered, a special subset of monocytes is produced with cancer-killing properties. One of the conditions was acute infection with SARS-CoV-2, the virus behind COVID-19. The authors had noticed that some patients with cancer who also had severe COVID saw a decrease in the size of their tumors.

These monocytes are unique in that they are not later converted to the cancer-friendly type by the body. They express a surface receptor that binds perfectly to a specific RNA sequence in SARS-CoV-2.

“If the monocyte was a lock, and the COVID RNA was a key, then COVID RNA is the perfect fit,” study author Dr Ankit Bharat told Live Science. 

Stebbing is quick to point out that this “certainly doesn’t mean people should actively try to catch COVID,” and we want to emphasize that message too. From their research, the authors believe they’ve hit on a way to induce this population of monocytes with a drug, rather than risking a bout of a nasty viral disease. 

Advertisement

Male and female mice with four different types of stage 4 cancer were assessed: lung cancer, colon cancer, breast cancer, and melanoma. They were given a drug to stimulate the immune system, mimicking the impact of a severe COVID-19 infection and inducing the production of the special monocytes. 

In all four cancer types, the tumors started to shrink after the treatment. 

While these findings are limited to mice for now, and clinical testing will be needed before anything can be translated into humans, the authors do point out that similar drugs are already approved for use in humans: “Given that NOD2 agonists have been approved for human use, our findings have potential clinical implications for patients with cancers resistant to current immunotherapies.”

Severe COVID-19 is life-threatening and particularly dangerous for those already dealing with serious diseases like cancer – but if we can turn some of its effects to our advantage while bypassing the actual “infection” part, that could be good news for everyone.

Advertisement

The study is published in The Journal of Clinical Investigation. 

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Twitter accelerates again with Bitcoin tips, NFTs, recorded Spaces, creator fund and more
  2. OPEC+ sticks to plan for gradual oil output hike, price roars higher
  3. Starseeds: Psychologists On Why Some People Think They’re Aliens Living On Earth
  4. What Are The Chances Of An Asteroid Hitting The Earth Soon?

Source Link: Severe COVID-19 Induces An Immune Response That May Be Able To Fight Cancer

Filed Under: News

Primary Sidebar

  • Unethical Experiments: When Scientists Really Should Have Stopped What They Were Doing Immediately
  • The First Humans Were Hunted By Leopards And Weren’t The Apex Predators We Thought They Were
  • Earth’s Passage Through The Galaxy Might Be Written In Its Rocks
  • What Is An Einstein Cross – And Why Is The Latest One Such A Unique Find?
  • If We Found Life On Mars, What Would That Mean For The Fermi Paradox And The Great Filter?
  • The Longest Living Mammals Are Giants That Live Up To 200 Years In The Icy Arctic
  • Entirely New Virus Detected In Bat Urine, And It’s Only The 4th Of Its Kind Ever Isolated
  • The First Ever Full Asteroid History: From Its Doomed Discovery To Collecting Its Meteorites
  • World’s Oldest Pachycephalosaur Fossil Pushes Back These Dinosaurs’ Emergence By 15 Million Years
  • The Hole In The Ozone Layer Is Healing And On Track For Full Recovery In The 21st Century, Thanks To Science
  • First Sweet Potato Genome Reveals They’re Hybrids With A Puzzling Past And 6 Sets Of Chromosomes
  • Why Is The Top Of Canada So Sparsely Populated? Meet The “Canadian Shield”
  • Humans Are In The Middle Of “A Great Evolutionary Transition”, New Paper Claims
  • Why Do Some Toilets Have Two Flush Buttons?
  • 130-Year-Old Butter Additive Discovered In Danish Basement Contains Bacteria From The 1890s
  • Prehistoric Humans Made Necklaces From Marine Mollusk Fossils 20,000 Years Ago
  • Zond 5: In 1968 Two Soviet Steppe Tortoises Beat Humans To Orbiting Around The Moon
  • Why Cats Adapted This Defense Mechanism From Snakes
  • Mother Orca Seen Carrying Dead Calf Once Again On Washington Coast
  • A Busy Spider Season Is Brewing: Why This Fall Could See A Boom Of Arachnid Activity
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version